Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3029612	s-listab	— (—)	94	126	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other maternal disorders predominantly related to pregnancy

6.26

15.22

1.3

1.4

—

False labour

7.76

14.45

1.4

1.3

—

Maternal care for other known or suspected fetal problems

7.93

14.17

1.4

1.3

—

Postpartum haemorrhage

6.13

12.55

1.4

1.3

—

Diabetes mellitus in pregnancy

5.51

11.51

1.3

1.4

—

Gestational diabetes (for exclusion)

4.24

11.07

1.4

1.3

—

Female infertility

6.00

10.24

1.2

1.4

—

Perineal laceration during delivery

5.48

10.21

1.3

—

Premature rupture of membranes

7.12

8.13

1.3

—

Postpartum hemorraghe, all women as controls

3.68

7.47

1.4

—

Special screening examination for infectious and parasitic diseases

7.75

7.39

1.5

1.2

—

Follow-up examination after treatment for conditions other than malignant neoplasms

7.08

6.87

1.3

1.2

—

Female infertility, cervical, vaginal, other or unspecified origin

4.94

6.83

1.2

1.4

—

Postpartum haemorrhage due to anatomy

3.81

6.52

1.3

1.4

—

Medical treatment for female infertility

3.77

6.42

1.4

—

Medical observation and evaluation for suspected diseases and conditions

5.11

6.40

1.4

1.2

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.28

6.31

1.4

—

Haemorrhage in early pregnancy

5.76

6.13

1.3

1.5

—

Female infertility, associated with anovulation

8.02

5.83

1.3

1.4

—

Other abnormal products of conception

3.53

5.77

1.2

1.4

—

Other obstetric conditions, not elsewhere classified

3.16

5.76

1.4

—

Other disorders of amniotic fluid and membranes

6.98

5.76

1.5

1.3

—

Abnormal findings on antenatal screening of mother

6.86

5.73

1.4

1.5

—

Postpartum hemorraghe, parous women as controls

3.01

5.34

1.4

—

Spontaneous abortion

3.35

5.15

1.4

—

Pregnancy with abortive outcome

3.13

5.14

1.2

1.4

—

General examination and investigation of persons without complaint and reported diagnosis

4.58

5.13

1.3

1.2

—

Maternal care for other conditions predominantly related to pregnancy

5.06

4.95

1.5

1.4

—

Persons encountering health services for examination and investigation

4.43

4.88

1.3

1.2

—

Infections with a predominantly sexual mode of transmission

3.33

4.85

1.4

—

Infections of genitourinary tract in pregnancy

8.20

4.56

1.4

—

Complications of labour and delivery

3.30

4.52

1.1

1.3

—

Other problems related to primary support group, including family circumstances

5.64

4.33

1.4

1.3

—

Excessive vomiting in pregnancy

8.91

4.28

1.6

1.3

—

Procreative management

9.41

4.22

1.5

1.4

—

Exposure to other specified factors

2.66

4.20

1.4

1.3

—

Other nutritional deficiencies

2.66

4.08

1.2

1.4

—

Obesity due to excess calories

2.88

3.89

1.2

1.4

—

Obesity

2.65

3.89

1.2

1.4

—

Obesity and other hyperalimentation

2.65

3.88

1.2

1.4

—

Symptoms and signs involving the digestive system and abdomen

2.76

3.86

1.4

1.3

—

Maternal care for known or suspected fetal abnormality and damage

4.91

3.84

1.4

1.3

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

4.10

3.83

1.4

1.3

—

Noninflammatory disorders of female genital tract

3.35

3.77

1.3

1.4

—

Certain infectious and parasitic diseases

2.62

3.56

1.3

—

Persons encountering health services in other circumstances, wide

2.57

3.47

1.3

—

Abdominal and pelvic pain

2.64

3.44

1.4

1.3

—

Nausea and vomiting

5.16

3.43

1.3

1.1

—

Persons encountering health services in circumstances related to reproduction

6.70

3.41

1.3

1.4

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2.43

3.34

1.6

1.3

—

Other sexually transmitted chlamydial diseases

5.73

3.34

1.5

1.3

—

Polycystic ovarian syndrome, broad definition

3.43

3.30

1.3

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.53

3.27

1.3

—

Placenta praevia

8.59

3.26

1.3

—

Maternal care for known or suspected malpresentation of fetus

4.13

3.25

1.3

—

Twin gestation

6.37

3.18

1.6

1.4

—

Multiple gestation

6.37

3.18

1.6

1.4

—

Excessive, frequent and irregular menstruation

3.11

3.08

1.3

1.4

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2.34

3.06

1.6

1.3

—

Labour and delivery complicated by fetal stress [distress]

2.94

3.00

1.4

1.3

—

Other sexually transmitted chlamydial diseases, including avohilmo

4.29

2.99

1.4

1.3

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2.34

2.90

1.5

1.3

—

Congenital malformations, deformations and chromosomal abnormalities

2.37

2.85

1.4

1.3

—

Symptoms and signs involving the urinary system

2.88

2.82

1.2

1.3

—

Endometriosis of pelvic peritoneum

5.31

2.79

1.3

—

Soft tissue disorders

2.11

2.77

1.3

—

Infections with a predominantly sexual mode of transmission, including avohilmo

2.32

2.72

1.4

—

Preterm labour and delivery

4.21

2.67

1.5

1.3

—

Failed induction of labour

4.68

2.59

1.3

1.4

—

Myalgia

4.00

2.56

1.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3.34

2.56

1.6

1.2

—

Depression or dysthymia

2.84

2.52

1.3

—

Contraceptive management

5.99

2.52

1.3

1.4

—

Maternal care for known or suspected abnormality of pelvic organs

3.38

2.49

1.2

1.3

—

Fissure and fistula of anal and rectal regions

4.38

2.47

1.1

1.3

—

Postpartum haemorrhage due to retained placenta

2.67

2.45

1.3

1.4

—

Pain (limb, back, neck, head abdominally)

2.59

2.44

1.4

1.2

—

Psychiatric diseases

2.27

2.38

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2.10

2.38

1.4

1.3

—

Medicines for HER+ breast cancer

4.08

2.31

1.1

1.3

—

Endocrine, nutritional and metabolic diseases

2.12

2.29

1.2

1.4

—

Polycystic ovarian syndrome, consortium definition

2.00

2.25

1.3

1.4

—

Colonic or urogenital fistula

3.89

2.25

1.1

1.3

—

L02BG Aromatase inhibitors

4.56

2.24

1.2

1.3

—

Haemorrhoids and perianal venous thrombosis

3.86

2.23

1.4

1.3

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2.68

2.20

1.5

1.4

—

Obesity, other/unspecified

2.68

2.20

1.2

1.5

—

Tonsillectomy and adenotomy

2.05

2.18

1.5

1.3

—

Any gastric operation

2.07

2.16

1.4

1.3

—

GASTRO-related operations

2.07

2.16

1.4

1.3

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2.38

2.14

1.4

—

Dysplasia of cervi uteri

3.01

2.05

1.7

1.4

—

Polycystic ovarian syndrome

3.51

2.05

1.3

1.4

—

Other arrhythmias

2.49

2.04

1.5

1.2

—

Congenital malformations of genital organs

3.98

2.02

1.2

1.3

—

Inflammatory diseases of female pelvic organs

1.98

2.02

1.4

—

Neurological diseases, wide definition

2.62

2.01

1.3

—

Acute upper respiratory infections

2.00

1.99

1.4

1.3

—

Caries of dentine, including avohilmo

2.46

1.96

1.3

1.4

—

Acute upper respiratory infections of multiple and unspecified sites

2.07

1.93

1.5

1.3

—

Hypothyroidism, levothyroxine purchases

2.49

1.90

1.2

1.3

—

Hypothyroidism and >3 levothyroxin purchases

2.49

1.90

1.3

—

Chronic diseases of tonsils and adenoids

2.03

1.90

1.5

1.3

—

Any mental disorder

2.02

1.88

1.3

—

Provisional assignment of new diseases of uncertain etiology

2.22

1.86

1.5

1.3

—

Codes for special purposes

2.22

1.86

1.5

1.3

—

Acute pharyngitis

3.15

1.85

1.3

1.2

—

Ectopic pregnancy

3.53

1.83

1.3

1.4

—

Epilepsy

3.03

1.79

1.3

—

Acetic acid derivatives and related substances

3.88

1.78

1.5

1.3

—

Bronchitis

1.83

1.76

1.5

1.3

—

Other congenital malformations

3.85

1.71

1.4

—

Oedema, not elsewhere classified

3.26

1.70

1.5

1.3

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2.87

1.69

1.3

—

Unspecified mental disorder

0.00

1.68

0.0

1.3

—

Gastrointestinal diseases

2.06

1.67

1.4

1.2

—

External causes of morbidity and mortality

2.06

1.67

1.4

1.3

—

Irregular menses

1.93

1.67

1.4

—

Injuries to the hip and thigh

2.85

1.66

1.3

1.2

—

Certain infectious and parasitic diseases, including avohilmo

2.25

1.65

1.3

—

Ovarian dysfunction

2.80

1.65

1.3

1.4

—

Anxiety disorders, excluding more controls

2.04

1.63

1.6

1.3

—

Antepartum haemorrhage, not elsewhere classified

3.57

1.61

1.4

—

Injury, poisoning and certain other consequences of external causes

2.13

1.58

1.4

1.3

—

Medical abortion

2.03

1.56

1.4

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.68

1.55

1.4

1.2

—

Cardiac arrhythmias

2.04

1.53

1.4

—

5-aminosalicylic acid

2.86

1.50

1.2

—

Other congenital malformations, including avohilmo

2.86

1.50

1.5

1.3

—

Hypothyroidism (congenital or acquired)

2.28

1.49

1.2

1.3

—

Pain in joint

2.25

1.49

1.5

1.2

—

Neurotic, stress-related and somatoform disorders

1.82

1.49

1.6

1.3

—

Long labour

2.46

1.48

1.3

—

Anxiety disorders

1.81

1.47

1.6

1.3

—

Inflammatory disease of uterus

2.50

1.45

1.4

1.2

—

Lyme disease, including avohilmo

2.73

1.43

1.2

—

Lyme disease

2.73

1.43

1.2

—

Spirochaetal infections, other/unspecified, including avohilmo

2.73

1.43

1.2

—

Other spirochaetal diseases

2.73

1.43

1.2

—

Other spirochaetal diseases, including avohilmo

2.73

1.43

1.2

—

Pre-eclampsia or poor fetal growth

1.96

1.41

1.4

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.86

1.38

1.5

1.4

—

Intestinal infectious diseases

1.76

1.37

1.4

1.3

—

Examination and observation for other reasons

2.65

1.37

1.4

1.2

—

Sulfasalazine

2.61

1.36

1.3

—

Kela-code for severe mental illness

0.00

1.32

0.0

1.3

—

Persons with potential health hazards related to communicable diseases

1.89

1.29

1.4

1.3

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2.78

1.28

1.2

1.3

—

Other soft tissue disorders, not elsewhere classified

1.71

1.27

1.4

1.3

—

Noninfective enteritis and colitis

2.04

1.26

1.1

1.3

—

IBD patients in KELA-register

2.40

1.24

1.2

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.69

1.24

1.8

1.3

—

Bacterial infection, other or unspecified

2.41

1.22

1.2

1.3

—

Vasomotor and allergic rhinitis

2.04

1.20

1.6

1.3

—

Asthma and allergy

2.60

1.19

1.4

1.3

—

Disease of hard tissues of teeth, NOS

2.62

1.18

1.3

—

Inflammatory bowel disease, strict (require KELA)

2.31

1.18

1.2

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

2.56

1.17

1.8

1.3

—

Depression medications

2.05

1.17

1.5

1.3

—

Poor fetal growth

2.05

1.15

1.3

1.4

—

Persons encountering health services for specific procedures and health care

0.50

1.14

1.0

1.4

—

KRA_PSY_EATING, excluding more controls

2.48

1.14

1.0

1.3

—

Intestinal infectious diseases, including avohilmo, including avohilmo

1.65

1.13

1.4

1.3

—

1.66

1.13

1.4

1.3

—

Acute sinusitis

1.85

1.12

1.4

1.3

—

Contact with and exposure to communicable diseases

1.84

1.11

1.3

1.4

—

Other reaction to severe stress, and adjustment disorders

1.90

1.11

1.5

1.2

—

Selective serotonin reuptake inhibitors

1.70

1.10

1.4

1.3

—

Other and unspecified tonsillitis

1.90

1.10

1.4

1.2

—

Ulcerative colitis

2.38

1.09

1.2

1.3

—

Diseases of the musculoskeletal system and connective tissue

1.80

1.08

1.3

—

Endometriosis ASRM stages 1,2

2.19

1.08

1.3

1.4

—

Asthma and allergy, excluding more controls

2.35

1.07

1.4

—

Anxiety (asthma-related co-morbidities)

1.74

1.07

1.7

1.3

—

Injuries to the knee and lower leg

1.58

1.06

1.3

1.4

—

Other heart diseases, wide

1.66

1.06

1.5

1.3

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.12

1.05

1.4

1.3

—

Covid-19 suspected case

2.12

1.05

1.6

1.2

—

Accidents

1.71

1.05

1.3

—

Persons encountering health services in other circumstances

2.10

1.04

1.3

1.2

—

Other antidepressants

1.67

1.04

1.4

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.71

1.04

1.4

1.3

—

Mood disorders, excluding more controls

1.75

1.03

1.4

1.3

—

Symptoms and signs involving the circulatory and respiratory systems

1.59

1.03

1.4

1.3

—

Allergic rhinitis

1.93

1.02

1.6

1.2

—

Autoimmune diseases

1.59

1.02

1.2

1.4

—

Parasetamol

1.68

1.01

1.3

1.4

—

Prolonged pregnancy

2.25

1.00

1.0

1.3

—

Other disorders of urethra and urinary system

1.71

0.99

1.1

1.4

—

Diseases of the skin and subcutaneous tissue

1.61

0.98

1.3

1.4

—

COPD/asthma/ILD related infections

1.64

0.98

1.3

—

COPD/asthma related infections

1.64

0.98

1.3

—

Other puerperal infections

0.00

0.96

0.0

1.3

—

Depression

1.60

0.96

1.4

—

Gestational [pregnancy-induced] hypertension

1.85

0.96

1.3

1.4

—

Cholecystectomy

1.78

0.94

1.4

1.3

—

Used for control exclusion in common control thyroid runs

1.57

0.94

1.2

1.4

—

Generalized anxiety disorder

1.89

0.94

1.4

1.2

—

Chronic sinusitis

1.89

0.94

1.4

1.3

—

Adverse effects, not elsewhere classified

2.14

0.91

1.7

1.2

—

All anxiety disorders

1.65

0.90

1.7

1.3

—

Systemic connective tissue disorders

2.07

0.89

1.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.93

0.89

1.5

1.3

—

Hypothyroidism, strict autoimmune

1.61

0.88

1.3

1.4

—

Childhood asthma (age<16)

2.04

0.87

1.2

1.3

—

Childhood asthma (age<16), excluding more controls

2.04

0.87

1.2

1.3

—

Allergic asthma (mode)

2.02

0.87

1.5

1.3

—

Allergic asthma (mode), excluding more controls

2.02

0.87

1.5

1.3

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1.86

0.87

1.4

1.3

—

Covid-19 confirmed case

2.00

0.86

1.3

—

Hypothyroidism, other/unspecified

1.55

0.86

1.3

1.4

—

Mycoses, including avohilmo

1.56

0.85

1.3

1.4

—

Inflammatory bowel disease treatment related agents

1.50

0.85

1.4

1.3

—

Asthma (only as main-diagnosis)

1.72

0.85

1.4

1.3

—

Pregnancy hypertension

1.64

0.85

1.4

—

Menorrhagia

1.97

0.83

1.3

1.5

—

Candidiasis, including avohilmo

1.74

0.82

1.3

—

Asthma (only as main-diagnosis), excluding more controls

1.70

0.82

1.4

1.3

—

Open wound of head

1.88

0.81

1.5

1.2

—

Other external causes of accidental injury

1.60

0.81

1.3

—

Meniscus derangement

0.00

0.79

0.0

1.2

—

Other benign neoplasms of skin

0.00

0.79

0.0

1.2

—

Bacterial infection, other or unspecified, including avohilmo

1.82

0.78

1.2

1.3

—

Other heart diseases

1.77

0.78

1.3

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.52

0.77

1.4

1.3

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.50

0.77

1.3

1.4

—

Other viral diseases, including avohilmo

1.71

0.77

1.2

1.4

—

Inflammatory bowel disease

1.76

0.76

1.2

1.3

—

Personal history of other diseases and conditions

2.16

0.76

1.6

1.3

—

Abnormalities of breathing

0.54

0.75

1.5

1.3

—

Other arthritis (FG)

2.08

0.74

1.4

1.2

—

Endometriosis

1.85

0.74

1.3

1.4

—

Injuries to the thorax

2.00

0.72

1.4

1.2

—

Other viral diseases

1.74

0.71

1.3

—

Eating disorder

1.92

0.70

1.0

1.3

—

Pain in limb

1.51

0.70

1.4

1.3

—

Autoimmune diseases related-to ILD

1.52

0.69

1.3

1.4

—

Dental caries, including avohilmo

1.71

0.69

1.1

1.5

—

Deforming dorsopathies

1.85

0.68

1.4

1.2

—

All dysplastic lesions of the cervix uteri

1.64

0.68

1.7

1.3

—

Sleep disorders (combined)

1.45

0.67

1.4

1.3

—

Fall on same level

0.63

0.66

1.2

1.4

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.63

0.66

1.7

1.3

—

Peritonsillar abscess

1.79

0.66

1.6

1.3

—

Suicide or other Intentional self-harm

1.79

0.66

1.4

1.3

—

Eating disorders

1.78

0.66

1.0

1.3

—

Disorders of breast

1.59

0.66

1.3

1.4

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.60

0.65

1.3

—

Diseases of the respiratory system

1.67

0.64

1.3

—

Injuries to the elbow and forearm

1.57

0.63

1.3

—

Disorders of other endocrine glands

1.64

0.62

1.3

1.4

—

Disorders of the thyroid gland

1.44

0.62

1.3

1.4

—

Superficial injury of wrist and hand

1.67

0.61

1.2

1.3

—

Sleep disorders

1.45

0.61

1.5

1.3

—

Exclusions for E4_PCOS_BROAD

0.00

0.60

0.0

1.3

—

Cervicalgia

0.00

0.60

0.0

1.2

—

Extrapyramidal and movement disorders

0.00

0.60

0.0

1.3

—

Migraine

1.49

0.60

1.3

1.4

—

Dentofacial anomalies [including malocclusion]

1.46

0.59

1.4

—

Bacterial Sepsis

0.00

0.59

0.0

1.3

—

Neurological diseases

1.42

0.59

1.2

1.4

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.54

0.59

1.5

1.3

—

Other pulmonary diagnosis

1.54

0.59

1.3

—

Gingivitis and periodontal diseases

1.47

0.58

1.1

1.4

—

Other intervertebral disc disorders

0.54

0.57

1.6

1.3

—

Periapical abscess

1.71

0.57

1.5

1.2

—

Other viral diseases, not elsewhere classified, including avohilmo

1.70

0.57

1.2

1.3

—

Disorders of lacrimal system

1.69

0.57

1.2

1.3

—

Recurrent or chronic depression

1.66

0.56

1.5

1.3

—

Pain in throat and chest

1.45

0.56

1.4

1.3

—

Genitourinary diseases

1.58

0.54

1.3

1.4

—

Ovarian cyst

1.56

0.53

1.0

1.4

—

Anaemias

1.54

0.52

1.5

1.3

—

Pollen allergy

1.52

0.52

1.2

1.3

—

Other and unspecified effects of external causes

1.50

0.51

1.7

1.3

—

Use of hypnotics and sedatives

0.64

0.50

1.1

1.4

—

Other diseases of upper respiratory tract

1.39

0.49

1.3

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.38

0.49

1.3

1.4

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.37

0.49

1.4

1.3

—

Childhood allergy (age < 16)

1.48

0.47

1.3

—

Oral corticosteroids

1.36

0.47

1.4

1.3

—

Asthma/COPD (KELA code 203)

0.68

0.47

1.5

1.3

—

Other disorders of skin and subcutaneous tissue

1.44

0.46

1.3

—

Cholelithiasis

1.48

0.46

1.5

1.3

—

Dental pulpitis, including avohilmo

1.35

0.46

1.4

1.3

—

Acne, including avohilmo

1.47

0.45

1.3

—

Migraine with aura

1.40

0.45

1.4

1.3

—

Mood [affective] disorders

1.35

0.44

1.3

1.4

—

Sciatica+with lumbago

1.38

0.44

1.7

1.3

—

Mood disorders

1.35

0.44

1.3

1.4

—

Dental operations

1.61

0.43

1.2

1.6

—

Coronary atherosclerosis

0.00

0.42

0.0

1.1

—

First line medication for Crohn's disease

1.31

0.42

1.4

1.3

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.42

0.42

1.1

1.3

—

Abnormalities of heart beat

1.56

0.42

1.2

—

Pre-eclampsia

1.56

0.42

1.6

1.3

—

Ischaemic heart disease, wide definition

0.00

0.42

0.0

1.1

—

Cholelithiasis, broad definition with cholecystitis

1.45

0.41

1.5

1.3

—

Diseases of middle ear and mastoid

1.36

0.41

1.2

1.4

—

Pre-eclampsia or eclampsia

1.52

0.41

1.6

1.3

—

Type1 diabetes, definitions combined, early onset

0.00

0.41

0.0

1.3

—

Type 1 diabetes, definitions combined

0.00

0.41

0.0

1.3

—

Type 1 diabetes, strict (exclude DM2)

0.00

0.41

0.0

1.3

—

Mental disorders, not otherwise specified

0.00

0.41

0.0

1.3

—

Other specified and unspecified personality disorders

0.00

0.41

0.0

1.3

—

Rosacea

0.00

0.41

0.0

1.3

—

Implicit viral Sepsis

0.00

0.41

0.0

1.2

—

Viral Sepsis

0.00

0.41

0.0

1.2

—

Other extrapyramidal and movement disorders in other diseases

0.00

0.41

0.0

1.3

—

Other diseases of urinary system

1.34

0.40

1.2

1.4

—

Impacted maxillary molar

0.00

0.40

0.0

1.4

—

Pain in thoracic spine

0.00

0.40

0.0

1.2

—

Cervical disc disorders

0.00

0.40

0.0

1.1

—

Other functional intestinal disorders

1.46

0.40

1.2

1.3

—

Superficial injury of ankle and foot

0.00

0.40

0.0

1.3

—

L04AA Selective immunosuppressants

0.00

0.40

0.0

1.3

—

Cellulitis

0.00

0.40

0.0

1.3

—

Asthma-related infections

1.32

0.40

1.5

1.3

—

Asthma, hospital admission 2, infections

1.32

0.40

1.5

1.3

—

Conjunctivitis (acute, non atopic), including avohilmo

1.34

0.39

1.2

1.4

—

Implicit bacterial Sepsis, including avohilmo

0.00

0.39

0.0

1.2

—

Poisoning by drugs, medicaments and biological substances

1.43

0.39

1.4

1.3

—

Other diseases of lip and oral mucosa

1.43

0.39

1.4

1.3

—

Excluding asthma or asthma-COPD overlap

1.41

0.39

1.3

—

Fracture of shoulder and upper arm

0.00

0.39

0.0

1.3

—

Viral infections characterized by skin and mucous membrane lesions

1.39

0.38

1.4

1.2

—

Other bacterial diseases

1.32

0.38

1.1

1.3

—

Diseases of pulp and periapical tissues and dental caries

1.54

0.38

1.2

1.5

—

Disorders of skin appendages

1.30

0.37

1.3

—

Disorders of choroid and retina

1.50

0.37

1.0

1.3

—

Other joint disorders

1.28

0.36

1.4

1.3

—

Substance abuse, excluding more controls

1.47

0.36

1.3

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.46

0.36

1.3

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.35

0.35

1.2

1.3

—

1.35

0.35

1.2

1.3

—

COPD differential diagnosis

1.38

0.35

1.3

—

ILD differential diagnosis

1.38

0.35

1.3

—

Asthma, unspecified (mode)

1.35

0.34

1.5

1.3

—

Asthma, unspecified (mode), excluding more controls

1.34

0.34

1.5

1.3

—

Asthma, hospital admissions , main diagnosis only

1.32

0.33

1.4

1.3

—

Fall on same level involving ice and snow

1.30

0.33

1.3

—

HSIL lesion of the cervix uteri

1.28

0.32

1.7

1.4

—

Dislocation, sprain and strain of joints and ligaments of knee

1.35

0.31

1.3

—

Insomnia

1.28

0.31

1.5

1.3

—

1.36

0.31

1.6

1.2

—

Caries of enamel

1.29

0.30

1.1

1.4

—

Mental and behavioural disorders due to psychoactive substance use

1.28

0.30

1.3

—

Arthropathies

1.24

0.30

1.3

—

Transport accidents

1.24

0.29

1.3

—

Nerve, nerve root and plexus disorders

0.75

0.28

1.2

1.4

—

Complications of medical and surgical care

1.28

0.28

1.3

1.4

—

Infections of the skin and subcutaneous tissue

1.29

0.28

1.1

1.3

—

Other diseases of intestines

1.23

0.28

1.2

1.4

—

Dermatophytosis, including avohilmo

1.24

0.27

1.3

—

Disorders of conjunctiva

1.26

0.26

1.3

—

Hernia

0.66

0.26

1.2

1.3

—

Asthma

1.32

0.26

1.5

1.3

—

Asthma, excluding more controls

1.32

0.25

1.5

1.3

—

Asthma (mode)

1.31

0.25

1.5

1.3

—

Biguanides

1.18

0.25

1.3

1.4

—

Polyarthropathies

1.18

0.25

1.2

1.4

—

Cardiovascular diseases

1.22

0.24

1.3

1.4

—

Fracture of lower leg, including ankle

1.29

0.23

1.6

1.3

—

Osteopathies and chondropathies

1.27

0.22

1.2

1.3

—

Mental and behavioural disorders due to alcohol

1.25

0.22

1.4

1.3

—

Major coronary heart disease event excluding revascularizations

0.00

0.22

0.0

1.1

—

Angina pectoris

0.00

0.22

0.0

1.1

—

Visual disturbances

1.22

0.22

1.0

1.3

—

Fenamates

0.00

0.22

0.0

1.3

—

Reimbursement for rheumatic diseases

1.21

0.22

1.6

1.3

—

COPD

0.00

0.21

0.0

1.1

—

Other chronic obstructive pulmonary disease

0.00

0.21

0.0

1.1

—

Other bacterial diseases, including avohilmo

0.76

0.21

1.1

1.4

—

Complications of surgical and medical care, not elsewhere classified

0.76

0.21

1.3

1.4

—

Heart failure,strict

0.00

0.21

0.0

1.1

—

Fracture of lumbar spine and pelvis

0.00

0.21

0.0

1.2

—

Desensitization to allergens

0.00

0.21

0.0

1.4

—

Contusion of other and unspecified parts of foot

0.00

0.21

0.0

1.3

—

Otalgia

0.00

0.21

0.0

1.2

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.21

0.0

1.3

—

Other and unspecified injuries of lower leg

0.00

0.21

0.0

1.2

—

Adalimumab

0.00

0.21

0.0

1.3

—

Purpura and other haemorrhagic conditions

0.00

0.21

0.0

1.3

—

Other inflammation of eyelid

0.00

0.21

0.0

1.2

—

Benign neoplasm of ovary

0.00

0.21

0.0

1.2

—

Zoster [herpes zoster]

0.00

0.21

0.0

1.1

—

Glomerular diseases

0.00

0.21

0.0

1.1

—

Nasal polyp

0.00

0.21

0.0

1.2

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.21

0.0

1.2

—

Benign neoplasm: Colon

0.00

0.21

0.0

1.1

—

Female genital prolapse

0.00

0.21

0.0

1.5

—

Fitting and adjustment of other devices

0.00

0.21

0.0

1.2

—

Open bite

0.00

0.21

0.0

1.3

—

Other and unspecified mood [affective] disorders

0.00

0.21

0.0

1.2

—

Herpesviral [herpes simplex] infections

0.00

0.21

0.0

1.2

—

Pruritus

0.00

0.21

0.0

1.3

—

Alcohol dependence

0.00

0.21

0.0

1.2

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.21

0.0

1.3

—

Type 1 diabetes, strict definition

0.00

0.21

0.0

1.3

—

COPD, hospital admissions

0.00

0.21

0.0

1.1

—

COPD, early/later onset

0.00

0.21

0.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

0.00

0.21

0.0

1.1

—

Mixed and other personality disorders

0.00

0.21

0.0

1.2

—

Chalazion

0.00

0.21

0.0

1.3

—

Restless leg syndrome

0.00

0.21

0.0

1.2

—

Injury of eye and orbit

0.00

0.21

0.0

1.3

—

Schizophrenia

0.00

0.21

0.0

1.2

—

Other diseases of blood and blood-forming organs, wide

0.00

0.21

0.0

1.2

—

Other diseases of the digestive system

0.00

0.21

0.0

1.2

—

GI-bleeding

0.00

0.21

0.0

1.2

—

All-cause Heart Failure

0.00

0.20

0.0

1.1

—

Heart failure, strict

0.00

0.20

0.0

1.1

—

Any event in cancer register

0.77

0.20

1.3

1.4

—

Implicit bacterial Sepsis

0.00

0.20

0.0

1.2

—

Complications of the puerperium, not elsewhere classified

0.00

0.20

0.0

1.4

—

Allergic contact dermatitis

0.00

0.20

0.0

1.3

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.20

0.0

1.4

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

0.20

0.0

1.2

—

Benign lipomatous neoplasm

0.00

0.20

0.0

1.2

—

HSIL lesion of the cervix uteri, vagina or vulva

1.25

0.20

1.7

1.4

—

Other and unspecified dermatitis

1.25

0.20

1.2

1.4

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.25

0.20

1.3

1.4

—

Fracture of forearm

1.22

0.20

1.3

—

Speech and linguistic disorders

0.00

0.20

0.0

1.3

—

Benign neoplasms

0.83

0.20

1.3

1.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.19

0.20

1.4

1.3

—

Pneumonia, organism unspecified

1.24

0.20

1.2

1.4

—

Headache

1.23

0.19

1.2

1.4

—

Influenza and pneumonia

1.19

0.19

1.2

1.4

—

Substance abuse

1.14

0.19

1.3

—

Second line medication for Crohn's disease

1.13

0.18

1.0

1.4

—

Exposure to unspecified factor

1.19

0.18

1.5

1.3

—

Lower back pain or/and sciatica

1.18

0.18

1.5

1.3

—

Temporomandibular joint disorders, including avohilmo

1.23

0.17

1.3

1.4

—

Autoimmune diseases excluding thyroid diseases

1.18

0.17

1.1

1.4

—

Nonsuppurative otitis media, including avohilmo

0.76

0.17

1.4

1.3

—

ILD medications: immunosuppressive drugs

0.75

0.17

1.0

1.4

—

Acute tubulo-interstitial nephritis

0.73

0.17

1.0

1.4

—

Other inflammation of eyelid, including avohilmo

0.71

0.16

1.4

—

Diseases of the eye and adnexa

0.83

0.16

1.1

1.3

—

Metabolic disorders

1.12

0.16

1.1

1.3

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.09

0.15

1.4

—

Other anxiety disorders

1.16

0.15

1.4

1.3

—

Excessive attrition of teeth

1.14

0.15

1.2

1.4

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

0.81

0.14

1.0

1.4

—

Injuries to the ankle and foot

0.79

0.13

1.3

—

Triptan medication for migraine, min. 3 purchases

0.83

0.13

1.3

1.4

—

Type 2 diabetes, strict (exclude DM1)

1.19

0.12

1.3

1.4

—

Type 2 diabetes, definitions combined

1.19

0.12

1.3

1.4

—

Opioids

1.13

0.12

1.4

1.3

—

All kidney diseases

0.86

0.12

1.1

1.4

—

Other dorsopathies, not elsewhere classified

0.88

0.10

1.5

1.3

—

Diseases of oesophagus, stomach and duodenum

0.87

0.10

1.3

1.4

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1.14

0.10

1.4

1.3

—

Visual disturbances and blindness

1.14

0.10

1.0

1.3

—

Codeine or tramadol medication

1.11

0.10

1.3

1.4

—

Antihypertensive medication - note that there are other indications

1.12

0.09

1.4

1.3

—

Diseases of the ear and mastoid process

1.11

0.09

1.4

—

Malaise and fatigue

1.06

0.09

1.2

1.4

—

1.06

0.09

1.4

1.2

—

Diseases of pulp and periapical tissues, including avohilmo

0.89

0.09

1.3

—

L04AX Other immunosuppressants

1.04

0.09

1.0

1.3

—

1.03

0.09

1.4

1.2

—

Hypertension, essential

1.09

0.09

1.0

1.3

—

Cystitis

1.13

0.09

1.3

1.4

—

Other acute lower respiratory infections

1.10

0.09

1.3

—

Codeine

1.11

0.08

1.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.12

0.08

1.2

1.4

—

Acute suppurative otitis media

0.82

0.08

1.2

1.4

—

Chronic apical periodontitis

0.90

0.08

1.4

1.3

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.05

0.08

1.3

—

Acute appendicitis, no complications

1.04

0.08

1.6

1.3

—

Suppurative and unspecified otitis media

0.84

0.07

1.2

1.4

—

Asthma (diagnoses ohter than nonallergic)

1.12

0.07

1.5

1.3

—

Episodal and paroxysmal disorders

1.10

0.07

1.4

1.3

—

Symptoms and signs involving the skin and subcutaneous tissue

1.06

0.07

1.1

1.4

—

Disorders of eyelid, lacrimal system and orbit

0.84

0.07

1.1

1.4

—

Acute appendicitis

1.02

0.07

1.5

1.3

—

Appendectomy

0.85

0.07

1.6

1.3

—

Conjunctivitis

1.12

0.07

1.4

—

Renal tubulo-interstitial diseases

0.87

0.07

1.1

1.4

—

Benzodiazepine use

1.10

0.06

1.6

1.3

—

General symptoms and signs

1.09

0.06

1.1

1.4

—

Finngen Rheumatological endpoints

1.09

0.05

1.4

1.3

—

Disorders of gallbladder, biliary tract and pancreas

1.11

0.05

1.5

1.3

—

Type 2 diabetes, definitions combined, including avohilmo

1.11

0.05

1.3

1.4

—

Neoplasms

1.08

0.04

1.1

1.4

—

Other (not insulin) diabetes medications

1.11

0.04

1.3

1.4

—

Asthma, including avohilmo

1.07

0.04

1.5

1.3

—

Other specific joint derangements/joint disorders

1.08

0.03

1.4

1.3

—

Falls/tendency to fall

0.93

0.03

1.4

—

ILD medications

1.05

0.01

1.4

1.3

—

Diabetes medication

0.94

0.01

1.3

1.4

—

Type 2 diabetes

1.06

0.00

1.3

1.4

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.06

0.00

1.5

1.3

—

Injuries to the head

0.96

0.00

1.4

1.3

—

Dorsalgia

1.04

0.00

1.5

1.3

—

Diabetes, varying definitions

1.04

0.00

1.2

1.4

—

Diabetes mellitus

1.00

0.00

1.3

1.4

—

All pneumoniae

1.04

0.00

1.2

1.4

—

Injuries to the wrist and hand

0.98

0.00

1.3

1.4

—

Pneumonias (Asthma/COPD co-morbidities)

1.04

0.00

1.2

1.4

—

Cardiovascular diseases (excluding rheumatic etc)

1.00

0.00

1.3

1.4

—

Triptan medication for migraine, single purchase ok

0.99

0.00

1.2

1.4

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

0.99

0.00

1.2

1.4

—

Any reimbursement code in KELA

1.00

0.00

1.2

1.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

0.99

0.00

1.2

1.4

—

Chronic lower respiratory diseases

1.00

0.00

1.4

1.3

—

Urinary track infection

1.04

0.00

1.3

1.4

—

Atopic dermatitis

1.03

0.00

1.1

1.4

—

Dorsopathies

1.00

0.00

1.5

1.3

—

Exclusions for E4_PCOS_CONSORTIUM

0.97

0.00

1.0

1.4

—

Dermatitis and eczema

0.97

0.00

1.2

1.4

—

Low back pain

1.05

0.00

1.3

—

Combinations of oral blood glucose lowering drugs

0.00

0.0

1.0

—

Malignant neoplasm of breast, HER-negative

0.00

0.0

1.2

—

DVT of lower extremities

0.00

0.0

1.1

—

Lichen planus

0.00

0.0

1.2

—

Polyneuropathies and other disorders of the peripheral nervous system

0.00

0.0

1.1

—

Other and unspecified drugs and medicaments

0.00

0.0

1.1

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.0

1.2

—

Exposure to other and unspecified animate mechanical forces

0.00

0.0

1.2

—

Other and unspecified injuries of ankle and foot

0.00

0.0

1.3

—

Mixed conductive and sensorineural hearing loss

0.00

0.0

1.2

—

Malignant neoplasm of breast, ER-negative, including Hilmo

0.00

0.0

1.2

—

Foreign body on external eye

0.00

0.0

1.2

—

Explicit bacterial Sepsis, including avohilmo

0.00

0.0

1.2

—

Sequelae of injuries of upper limb

0.00

0.0

1.1

—

Dizziness and giddiness

0.97

0.00

1.0

1.4

—

LeFortI or BSSO operation

0.00

0.0

1.3

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.95

0.00

1.3

—

Monoamine oxidase A inhibitors

0.00

0.0

1.0

—

Other disorders of cornea

0.00

0.0

1.1

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.1

—

Nonspecific lymphadenitis

0.00

0.0

1.2

—

Other noninfective disorders of lymphatic vessels and lymph nodes

0.00

0.0

1.2

—

Hypoplasia of dental enamel , including avohilmo

0.00

0.0

1.2

—

Necrosis of pulp, including avohilmo

0.88

0.00

1.0

1.4

—

Constipation

0.99

0.00

1.2

1.3

—

Other specified/unspecified inflammatory spondylopathies

0.00

0.0

1.1

—

Conductive hearing loss, unspecified

0.00

0.0

1.1

—

Other appendicitis

0.00

0.0

1.1

—

Benign neoplasm of meninges

0.00

0.0

1.2

—

Benign neoplasm of major salivary glands

0.00

0.0

1.1

—

Lesion of ulnar nerve

0.00

0.0

1.1

—

Cerebral cysts

0.00

0.0

1.2

—

Use of pramipexole

0.00

0.0

1.1

—

COPD, hospital admissions 1, only main diagnosis

0.00

0.0

1.0

—

Malignant melanoma of skin, including Hilmo

0.00

0.0

1.2

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.0

1.1

—

Enterobiasis, including avohilmo

0.00

0.0

1.2

—

Congenital deformities of feet, including avohilmo

0.00

-0.00

0.0

1.2

—

Nonsuppurative otitis media

0.92

-0.00

1.4

1.3

—

Bilateral sagittal split ramus osteotomy operation

0.00

-0.00

0.0

1.2

—

Spondylopathies

0.87

-0.00

1.4

1.3

—

Foreign body or object entering through skin

0.00

-0.00

0.0

1.0

—

Persistent delusional disorders

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of endocrine gland, including Hilmo

0.00

-0.00

0.0

1.2

—

Nephropathy related operations

0.00

-0.00

0.0

1.2

—

Other disorders of the genitourinary system

0.00

-0.00

0.0

1.1

—

Glomerular disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

Other disorders of bladder

0.00

-0.00

0.0

1.2

—

Exposure to other and unspecified inanimate mechanical forces

0.00

-0.00

0.0

1.2

—

Leiomyoma of uterus

0.88

-0.00

1.0

1.3

—

Struck by thrown, projected or falling objec

0.00

-0.00

0.0

1.2

—

Use of interferon beta-1a

0.00

-0.00

0.0

1.2

—

Dermatophytosis

0.00

-0.00

0.0

1.2

—

Allergic conjunctivitis

1.01

-0.00

1.4

—

Blepharochalasis

0.00

-0.00

0.0

1.1

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

0.00

-0.00

0.0

1.2

—

Adjustment and management of implanted device

0.00

-0.00

0.0

1.1

—

Implicit fungal Sepsis, including avohilmo

0.00

-0.00

0.0

1.2

—

Divergent concomitant strabismus

0.00

-0.00

0.0

1.1

—

Soft tissue disorders related to use, overuse and pressure

0.00

-0.00

0.0

1.3

—

Episcleritis

0.00

-0.00

0.0

1.2

—

Pedestrian injured in transport accident

0.00

-0.00

0.0

1.2

—

Other disorders of bone density and structure

0.00

-0.00

0.0

1.2

—

Other benign neoplasms of connective and other soft tissue

0.00

-0.00

0.0

1.1

—

Chronic periodontitis, including avohilmo

1.01

-0.00

1.2

1.4

—

Benign neoplasm: salivary glands, exclude unknown (D119)

0.00

-0.00

0.0

1.2

—

Achilles tendinitis

0.00

-0.00

0.0

1.1

—

Scar conditions and fibrosis of skin

0.00

-0.00

0.0

1.2

—

Toxic effect of ethanol

0.00

-0.00

0.0

1.2

—

Idiopathic urticaria

0.00

-0.00

0.0

1.2

—

Lichen planus, including avohilmo

0.00

-0.00

0.0

1.1

—

0.00

-0.00

0.0

1.4

—

severe traumatic brain injury, does not include concussion

0.00

-0.00

0.0

1.1

—

Presence of cardiac and vascular implants and grafts

0.00

-0.00

0.0

1.1

—

Hypertension

0.85

-0.00

1.0

1.3

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

-0.00

0.0

1.2

—

Atypical facial pain

0.00

-0.00

0.0

1.2

—

Gastric ulcer

0.00

-0.00

0.0

1.0

—

Speech and linguistic disorders, excluding more controls

0.00

-0.00

0.0

1.0

—

Scleritis and episcleritis

0.00

-0.00

0.0

1.2

—

Gastroduodenal ulcer

0.00

-0.00

0.0

1.1

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

0.00

-0.00

0.0

1.1

—

Myocardial infarction

0.00

-0.00

0.0

1.0

—

Ingrowing nail

0.00

-0.00

0.0

1.2

—

Crohn disease (strict definition, all UC cases excluded)

0.00

-0.00

0.0

1.2

—

Intestinal malabsorption

0.00

-0.00

0.0

1.2

—

Other diseases of oesophagus

0.00

-0.00

0.0

1.2

—

Viral meningitis

0.00

-0.00

0.0

1.2

—

Periodontitis

0.99

-0.00

1.2

1.4

—

Nontraumatic intracranial haemmorrhage

0.00

-0.00

0.0

1.2

—

Diseases of appendix

0.97

-0.00

1.5

1.3

—

Hyperprolactinaemia

0.00

-0.00

0.0

1.2

—

Other osteochondropathies

0.00

-0.00

0.0

1.2

—

Other inflammatory liver diseases

0.00

-0.00

0.0

1.2

—

Dermatitis due to ingested food

0.00

-0.00

0.0

1.2

—

Ulcer of lower limb, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Drug-induced neutropenia

0.00

-0.00

0.0

1.0

—

Myocardial infarction, strict

0.00

-0.00

0.0

1.0

—

Rash and other nonspecific skin eruption

0.00

-0.00

0.0

1.3

—

Hypertensive diseases

0.85

-0.00

1.0

1.3

—

Other embolism and thrombosis

0.00

-0.00

0.0

1.1

—

Diseases of peritoneum

0.00

-0.00

0.0

1.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

-0.00

0.0

1.2

—

Cerebral palsy and other paralytic syndromes

0.00

-0.00

0.0

1.1

—

Chronic laryngitis and laryngotracheitis

0.00

-0.00

0.0

1.0

—

Astigmatism

0.00

-0.00

0.0

1.3

—

Disorders of synovium and tendon

0.99

-0.00

1.0

1.4

—

Hyperfunction of pituitary gland

0.00

-0.00

0.0

1.1

—

Aortic valve malfunction, age under 60 years

0.00

-0.00

0.0

1.2

—

Specific development disorders of speech and language

0.00

-0.00

0.0

1.1

—

Dermatitis

0.96

-0.00

1.2

1.4

—

Other disorders of ear

0.88

-0.00

1.2

1.3

—

Other peripheral vertigo

0.00

-0.00

0.0

1.2

—

Thrombocytopenia, unspecified

0.00

-0.00

0.0

1.2

—

Papillary adenocarcinoma of thyroid gland

0.00

-0.00

0.0

1.2

—

Pacemaker

0.00

-0.00

0.0

1.1

—

Suppurative otitis media, unspecified

0.00

-0.00

0.0

1.2

—

Chronic suppurative otitis media, including avohilmo

0.00

-0.00

0.0

1.2

—

Injuries to the shoulder and upper arm

0.89

-0.00

1.0

1.3

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

-0.00

0.0

1.3

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

-0.00

0.0

1.2

—

Malignant melanoma

0.00

-0.00

0.0

1.2

—

Haemangioma, any site

0.00

-0.00

0.0

1.1

—

Non-ischemic cardiomyopathy

0.00

-0.00

0.0

1.1

—

Benign mammary dysplasia

0.00

-0.00

0.0

1.1

—

Vitreous haemorrhage

0.00

-0.00

0.0

1.2

—

Trigeminal neuralgia

0.00

-0.00

0.0

1.2

—

Herpesviral keratitis and keratoconjunctivitis

0.00

-0.00

0.0

1.2

—

Other diseases of intestine

0.00

-0.00

0.0

1.2

—

Appendicitis, broad definition

0.97

-0.00

1.5

1.3

—

Schizoaffective disorder

0.00

-0.00

0.0

1.2

—

Myocardial infarction, without ST-elevation

0.00

-0.00

0.0

1.0

—

Glomerulonephritis

0.00

-0.00

0.0

1.2

—

Glaucoma suspect

0.00

-0.00

0.0

1.1

—

Chronic iridocyclitis

0.00

-0.00

0.0

1.2

—

Hordeolum and other deep inflammation of eyelid

0.00

-0.00

0.0

1.2

—

Other infective otitis externa

0.00

-0.00

0.0

1.2

—

Other CVD

0.00

-0.00

0.0

1.0

—

Agranulocytosis

0.00

-0.00

0.0

1.1

—

Dissociative [conversion] disorders

0.00

-0.00

0.0

1.0

—

Other and unspecified iridocyclitis

0.00

-0.00

0.0

1.2

—

Melanocytic naevi of lower limb, including hip

0.00

-0.00

0.0

1.2

—

Other disorders of optic [2nd] nerve and visual pathways

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

-0.00

0.0

1.2

—

Helminthiases, including avohilmo

0.00

-0.00

0.0

1.2

—

Algoneurodystrophy

0.00

-0.00

0.0

1.2

—

Early onset COPD

0.00

-0.00

0.0

1.1

—

Other otitis externa (chronic)

0.00

-0.00

0.0

1.2

—

Disorders of eyelid in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

Dystonia

0.00

-0.00

0.0

1.2

—

Other and unspecified polyneuropathies, also in other diseases

0.00

-0.00

0.0

1.2

—

Sleep apnoea

0.92

-0.00

1.3

—

Enterocolitis due to Clostridium difficile

0.00

-0.00

0.0

1.2

—

Primary gonarthrosis, bilateral

0.00

-0.00

0.0

1.1

—

Disorders of speech understanding and production

0.00

-0.00

0.0

1.2

—

Cluster headache, strict, including avohilmo

0.00

-0.00

0.0

1.2

—

Specific development disorders of scholastic skills

0.00

-0.00

0.0

1.3

—

Mixed disorders of conduct and emotions

0.00

-0.00

0.0

1.2

—

Nonalcoholic fatty liver disease

0.00

-0.00

0.0

1.1

—

Agoraphobia

0.00

-0.00

0.0

1.1

—

Explicit bacterial Sepsis

0.00

-0.00

0.0

1.2

—

Cluster headache, wide,, including avohilmo

0.00

-0.00

0.0

1.2

—

Hypoglycaemia, other or unspecified

0.00

-0.00

0.0

1.2

—

Care involving dialysis

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of endocrine gland

0.00

-0.00

0.0

1.2

—

Chronic viral hepatitis

0.00

-0.00

0.0

1.2

—

Maternal care for known or suspected disproportion

0.00

-0.00

0.0

1.2

—

Dialysis, with operation codes

0.00

-0.00

0.0

1.2

—

Immunodeficiencies

0.00

-0.00

0.0

1.2

—

COPD, hospital admission 2, with asthma infections

0.00

-0.00

0.0

1.0

—

Event of undetermined intent

0.00

-0.00

0.0

1.2

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

1.0

—

Benign leiomyoma with endometriosis

0.00

-0.00

0.0

1.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

0.00

-0.00

0.0

1.1

—

Other endocrine disorders

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

-0.00

0.0

1.1

—

Collagenous colitis

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of thyroid gland

0.00

-0.00

0.0

1.2

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

-0.00

0.0

1.2

—

COPD related to multimorbidity

0.00

-0.00

0.0

1.0

—

Cardiodefibrillation

0.00

-0.00

0.0

1.0

—

Malignant melanoma of skin

0.00

-0.00

0.0

1.2

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

-0.00

0.0

1.2

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

1.2

—

Crossbite

0.00

-0.00

0.0

1.2

—

Hypertensive diseases (excluding secondary)

0.91

-0.00

1.0

1.3

—

Viral meningitis, including avohilmo

0.00

-0.00

0.0

1.2

—

Malignant melanoma, including Hilmo

0.00

-0.00

0.0

1.2

—

Use of disulfiram, acamprosate or naltrexone

0.00

-0.00

0.0

1.2

—

malignant neoplasm of female genital organs, including Hilmo

0.00

-0.00

0.0

1.1

—

Complications of procedures, not elsewhere classified

0.89

-0.00

1.3

1.4

—

Benign neoplasm: Skin of trunk

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Sigmoid colon

0.00

-0.00

0.0

1.2

—

Sequelae of injuries of head

0.00

-0.00

0.0

1.2

—

Cramp and spasm

0.00

-0.00

0.0

1.2

—

Infective dermatitis

0.00

-0.00

0.0

1.3

—

Contusion of toe(s) without damage to nail

0.00

-0.00

0.0

1.2

—

Sleep apnoea, including avohilmo

0.93

-0.00

1.3

1.4

—

Other and unspecified rosacea

0.00

-0.00

0.0

1.1

—

Abnormal serum enzyme levels

0.00

-0.00

0.0

1.1

—

Other and unspecified injuries of wrist and hand

0.00

-0.00

0.0

1.2

—

L04AD Calcineurin inhibitors

0.00

-0.00

0.0

1.1

—

Mixed disorders of conduct and emotions, excluding more controls

0.00

-0.00

0.0

1.0

—

Ménière disease

0.00

-0.00

0.0

1.2

—

Viral and other specified intestinal infections, including avohilmo

1.00

-0.00

1.2

1.3

—

Other complications of surgical and medical care, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

-0.00

0.0

1.1

—

Other congenital malformations of face and neck

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.2

—

Ptosis of eyelid

0.00

-0.00

0.0

1.2

—

Hidradenitis suppurativa

0.00

-0.00

0.0

1.1

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Listeria sp Ab [Titer] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS